Electra Therapeutics files Form 3 as Westlake BioPartners Fund I reports beneficial ownership
E
ETRA• Westlake BioPartners Fund I reported indirect ownership of 3,527,136 common shares.Westlake BioPartners Fund II reported indirect ownership of 2,820,403 common shares.Shares were received via automatic 1:1 conversion of redeemable preferred stock at the IPO closing, with no additional consideration.Form 3 filing and ownership reporting
Electra Therapeutics filed a Form 3 on Sept. 21, 2026, showing Westlake BioPartners entities reporting 10% beneficial ownership.
Electra Therapeutics files Form 3 as Westlake BioPartners Fund I reports beneficial ownership - ETRA News | Rallies